Debra Patt, President of the Community Oncology Alliance, Executive Vice President Policy and Strategy at Texas Oncology, shared on LinkedIn:
“It was an incredible experience to participate in the KSMO meeting in Seoul, South Korea, and to represent ASCO by chairing the joint session on artificial intelligence in oncology.
The session highlighted the importance of collaboration as we work together to advance innovation in cancer care.
By sharing perspectives and experiences with colleagues from Europe, Asia, Australia, and around the world, we learn from one another and discover new ways to improve how AI can support patients, clinicians, and researchers.
This meeting was a wonderful opportunity to exchange ideas, learn from global leaders, and build meaningful new friendships. I’m grateful to everyone who contributed to such an inspiring and forward-looking discussion.
Together, through international collaboration, we can innovate better and shape the future of oncology.”
Debra Patt was recognized among OncoDaily’s The 100 Most Influential Women in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
You can also read: How Artificial Intelligence Is Supporting Earlier Lung Cancer Detection in the Middle East and Africa – LAA MEA
Leave a Reply